The Editor retracts “Mitochondria-Targeted Cassic Acid Base Nanoprodrug for Enhanced Anti-Inflammatory and Osteogenic Effects in Osteoarthritis” (ACS Omega 2025, 10, 32, 35940–35953, DOI: 10.1021/acsomega.5c03216) due to an internal image duplication in Figure 5a and noted inconsistencies between the published results and raw data of Figures 2a, 2c, 9a, 9b, and 9c. This has resulted in a loss of confidence in the results. As such, the Article is being retracted.
The original article was published on August 11, 2025, and was retracted on April 16, 2026.